PISKEL KYLE (Corporate Controller) sold 6.7% of their position (18.67K shares) of ADAPTIVE BIOTECHNOLOGIES CORP on the open market
Open‑market sale worth $245.9K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/13/2026ACC: 0001780662-26-000006
Officer· Corporate Controller
Since Jun 2019
-18.67K
Net shares
Net seller
$245.9K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
18.67K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−18.67K
Price / share
$13.17
Trade value
$245.91K
% of position
6.7%
3/11/2026
278.51K→259.84K
Total
Net shares
−18.67K
Net value
-$245.91K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/11/2026 | S · Sale | −18.67K | $13.17 | $245.91K | 6.7% | 278.51K | 259.84K |
| Total | −18.67K | -$245.91K | ||||||
Derivative Transactions0
No derivative transactions reported